Bottom line
PTH vs GGHCX: the short answer
PTH (Invesco Dorsey Wright Healthcare Momentum ETF) and GGHCX (INVESCO Health Care Fund) are both etfs.
PTH is cheaper at 0.6% vs 1.07% — a difference of $47 a year per $10,000 invested.
Over five years, GGHCX returned +2.6% a year vs −0.8% for PTH.
GGHCX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
PTH vs GGHCX side by side
| PTH | GGHCX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Invesco | Invesco |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.6% | 1.07% |
| Annual cost per $10k | $60 | $107 |
| 10-yr cost on $10k (prospectus) | $891 | $1,784 |
| Max front load | None | 5.5% |
| 12b-1 fee | — | 0.25% |
| 1-yr return | +28.1% | +9.2% |
| 5-yr return (annualized) | −0.8% | +2.6% |
| 10-yr return (annualized) | +10.8% | +5.8% |
| Best quarter | +43.5% | +19.6% |
| Worst quarter | −27.6% | −16.5% |
| Net assets (fund) | $235.2M | $1.2B |
| Number of holdings | 57 | 82 |
| Portfolio turnover | 239% | 59% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | PTH | GGHCX | Difference |
|---|---|---|---|
| 2025 | +28.1% | +15.5% | +12.6% |
| 2024 | +2.0% | +4.0% | −1.9% |
| 2023 | −4.4% | +3.1% | −7.4% |
| 2022 | −20.7% | −13.5% | −7.1% |
| 2021 | −3.0% | +12.2% | −15.2% |
| 2020 | +67.1% | +14.5% | +52.7% |
| 2019 | +33.8% | +32.0% | +1.8% |
| 2018 | −0.9% | +0.5% | −1.3% |
| 2017 | +50.1% | +15.5% | +34.7% |
| 2016 | −12.9% | −11.7% | −1.2% |
Source: Fund prospectus bar charts
Holdings overlap
5 of PTH's top 25 holdings also appear in GGHCX's top 25.
| Holding | PTH | GGHCX |
|---|---|---|
| Invesco Private Prime Fund | 20.79% | 4.67% |
| Invesco Private Government Fund | 6.84% | 1.80% |
| Guardant Health, Inc. | 4.97% | 2.04% |
| Axsome Therapeutics, Inc. | 4.12% | 1.58% |
| BrightSpring Health Services, Inc. | 4.03% | 2.20% |
Source: SEC Form N-PORT
PTH top 10
- Invesco Private Prime Fund — 20.79%
- Invesco Private Government Fund — 6.84%
- Guardant Health, Inc. — 4.97%
- Roivant Sciences Ltd. — 4.95%
- Revolution Medicines, Inc. — 4.94%
- Axsome Therapeutics, Inc. — 4.12%
- BrightSpring Health Services, Inc. — 4.03%
- Liquidia Corp. — 3.01%
- Erasca, Inc. — 2.94%
- Oruka Therapeutics, Inc. — 2.74%
GGHCX top 10
- Eli Lilly and Co. — 10.59%
- Johnson & Johnson — 6.76%
- UnitedHealth Group Inc. — 6.17%
- Invesco Private Prime Fund — 4.67%
- Merck & Co., Inc. — 4.59%
- AbbVie Inc. — 4.03%
- Gilead Sciences, Inc. — 3.63%
- argenx SE — 3.24%
- CVS Health Corp. — 2.52%
- Welltower Inc. — 2.34%
FAQ
What is the difference between PTH and GGHCX?
Which is cheaper, PTH or GGHCX?
Should I own both PTH and GGHCX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.